Urun, Yuksel Yasar, H Arzu Turna, Hande Esin, Ece Sedef, A Murat Alkan, Ali Oksuzoglu, Berna Ozdemir, Nuriye Sendur, MA Nahit Sezer, Ahmet Kılıckap, Saadettin Utkan, Gungor Akman, Tulay Akbulut, Hakan Celik, Ismail Abalı, Huseyin Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study <p>Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study by Yuksel Urun, H Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, MA Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Tulay Akman, Hakan Akbulut, Ismail Celik and Huseyin Abalı in Journal of Oncology Pharmacy Practice</p> Ipilimumab;melanoma;prognostic factors;absolute lymphocytes count 2018-11-06
    https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_Prognostic_factors_for_survival_in_patients_with_metastatic_malign_melanoma_treated_with_ipilimumab_Turkish_Oncology_Group_study/7343366
10.25384/SAGE.7343366.v1